IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Computational Approaches for the Discovery of Novel Hepatitis C Virus NS3/4A and NS5B Inhibitors

Computational Approaches for the Discovery of Novel Hepatitis C Virus NS3/4A and NS5B Inhibitors
View Sample PDF
Author(s): Khac-Minh Thai (University of Medicine and Pharmacy at HCMC, Vietnam), Quoc-Hiep Dong (University of Medicine and Pharmacy at HCMC, Vietnam), Thi-Thanh-Lan Nguyen (University of Medicine and Pharmacy at HCMC, Vietnam), Duy-Phong Le (University of Medicine and Pharmacy at HCMC, Vietnam), Minh-Tri Le (University of Medicine and Pharmacy at HCMC, Vietnam)and Thanh-Dao Tran (University of Medicine and Pharmacy at HCMC, Vietnam)
Copyright: 2015
Pages: 36
Source title: Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment
Source Author(s)/Editor(s): Kunal Roy (Jadavpur University, India)
DOI: 10.4018/978-1-4666-8136-1.ch009

Purchase

View Computational Approaches for the Discovery of Novel Hepatitis C Virus NS3/4A and NS5B Inhibitors on the publisher's website for pricing and purchasing information.

Abstract

Nonstructural 5B (NS5B) polymerase and Nonstructural 3/4A (NS3/4A) protease have proven to be promising targets for the development of anti-HCV (Hepatitis C Virus) agents. The NS5B polymerase is of paramount importance in HCV viral replication; therefore, employing NS5B inhibitors was considered an effective way for the treatment of HCV. Identifying inhibitors against NS3/4A serine protease represents another attractive approach applied in anti-HCV drug discovery, which is evidenced by its crucial role of in the biogenesis of the viral replication activity. In this chapter, many different computational approaches including Quantitative Structure-Activity Relationship (QSAR) and virtual screening in anti-HCV drug discovery were considered and discussed in detail. Virtual Screening (VS) techniques, including ligand-based and structure-based, and QSAR have been utilized for the discovery of NS5B inhibitors. Moreover, using various in silico protocols and workflows, a number of studies have been conducted with an aim of identifying potential NS3/4A blockage agents.

Related Content

Abul Kalam Azad, Mohamad Dayoob, Fatema Tuz Zohera. © 2024. 21 pages.
W. H. P. A. D. Perera, Mithuni N. Senadeera, Dinusha N. Udukala. © 2024. 26 pages.
Thi Van Anh Nguyen, Trang Nguyen Ngoc, Thanh Tung Bui. © 2024. 43 pages.
Abul Kalam Azad, Mallari Praveen, Wan Mohd Azizi Bin Wan Sulaiman. © 2024. 31 pages.
Bancha Yingngam. © 2024. 43 pages.
Babi Lakkoju, Swapna Asuthkar, Gundla Rambabu, Kolli Balakrishna. © 2024. 20 pages.
Arthi Gunasekaran, Trisha Sathya, Vijaya Anand Arumugam, Balamuralikrishnan Balasubramanian, Asirvatham Alwin Robert, Arun Meyyazhagan. © 2024. 31 pages.
Body Bottom